18
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      Are you tired of sifting through news that doesn't interest you?
      Personalize your Karger newsletter today and get only the news that matters to you!

      Sign up

      • Record: found
      • Abstract: found
      • Article: found

      Coagulative, Fibrinolytic and Metabolic Pattern in Patients with Central Retinal Vein Occlusion

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Central retinal vein occlusion (CRVO) is an important cause of visual loss. Many risk factors have been associated with CRVO onset at various ages. Among them diabetes mellitus, hypertension, immunologic disorders, increase in blood viscosity and coagulation, decrease of fibrinolysis have been reported in many subjects. The aim of our study was to detect the metabolic, coagulative and fibrinolytic pattern in 54 patients (26 men, 28 women, mean age 50.4 ± 12.3) affected by CRVO. We excluded from the study patients with other ocular disorders. A fibrinolytic impairment is the most common feature in our population. It occurs either in dysmetabolic or in nonmetabolic subjects. Such data suggest a prominent role of the fibrinolytic system in the pathogenesis of CRVO.

          Related collections

          Most cited references2

          • Record: found
          • Abstract: found
          • Article: not found

          Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion.

          Central retinal vein occlusion is a disease that is most common in old people, and often associated with atherosclerosis, hypertension, diabetes or glaucoma. Since these diseases are much less evident in young people, we wanted to investigate the prevalence of disorders in the most common anticoagulant proteins in a group of young patients with central retinal vein occlusion.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion

              Bookmark

              Author and article information

              Journal
              OPH
              Ophthalmologica
              10.1159/issn.0030-3755
              Ophthalmologica
              S. Karger AG
              0030-3755
              1423-0267
              2002
              April 2002
              02 April 2002
              : 216
              : 2
              : 108-112
              Affiliations
              aDepartment of Ophthalmology and Neurosurgery, and bInstitute of Medical Semeiotics, ‘Centro per lo Studio delle Malattie Dismetaboliche e della Aterosclerosi’, University of Siena, Italy
              Article
              48308 Ophthalmologica 2002;216:108–112
              10.1159/000048308
              11919435
              dba80e2c-77af-4033-988d-66a4e4401957
              © 2002 S. Karger AG, Basel

              Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

              History
              Page count
              Tables: 2, References: 28, Pages: 5
              Categories
              Original Paper · Travail original · Originalarbeit

              Vision sciences,Ophthalmology & Optometry,Pathology
              Central retinal vein occlusion,Fibrinolysis,Coagulation

              Comments

              Comment on this article